BioWorld-International-2005-08-10
Santhera Licenses European Idebenone Rights To Takeda
Santhera Licenses European Idebenone Rights To Takeda
Santhera Pharmaceuticals AG licensed to Takeda the European rights to its Friedreich's Ataxia (FRDA) treatment, idebenone, in a deal which earned it an up-front payment of EUR5 million (US$6.2 million). (BioWorld International)

